Hyperglycemia treatment includes many classes of drugs, one of which is sodium-glucose cotransporter 2 (SGLT2) inhibitors, which were proven to have pleiotropic effects expressed as a reduction in cardiovascular risk [104]. Here, SLC5A2 is linked to Hyperglycemia.